FCMI

Foresite Capital Management IV Portfolio holdings

AUM $230M
1-Year Est. Return 64.1%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+64.1%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$218M
AUM Growth
-$87.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
26
New
Increased
Reduced
Closed

Top Buys

1
+$12.3M
2
+$9.96M
3
+$5.79M
4
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$5.14M
5
SIBN icon
SI-BONE Inc
SIBN
+$3.89M

Top Sells

1
+$16.7M
2
+$8.69M
3
+$8.21M
4
ABUS icon
Arbutus Biopharma
ABUS
+$5.39M
5
XENE icon
Xenon Pharmaceuticals
XENE
+$5.09M

Sector Composition

1 Healthcare 85.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$31.7M 14.53%
855,900
+4,700
2
$25.9M 11.91%
1,977,236
+176,649
3
$23.8M 10.91%
486,624
-24,620
4
$20.7M 9.5%
2,631,258
+607,889
5
$17.2M 7.9%
1,205,363
-26,180
6
$15.4M 7.06%
245,424
7
$12.3M 5.64%
1,229,656
8
$10.8M 4.94%
400,000
-296,903
9
$10.6M 4.86%
113,903
+16,667
10
$10.5M 4.83%
+66,836
11
$9.45M 4.34%
+261,823
12
$6.06M 2.78%
1,582,275
-1,094,550
13
$5.94M 2.73%
431,781
-93,219
14
$5.53M 2.54%
748,132
+218,581
15
$4.88M 2.24%
+250,000
16
$4.29M 1.97%
+205,621
17
$1.8M 0.82%
63,922
-30,555
18
$1.11M 0.51%
+175,148
19
– –
-49,600
20
– –
-356,000
21
– –
-10,650
22
– –
-295,000
23
– –
-8,302
24
– –
-385,714
25
– –
-175,000
1
2